Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tasigna in Glivec-resistant or Intolerant Patients in CML

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Novartis Korea Ltd..
Recruitment status was  Recruiting
Information provided by:
Novartis Korea Ltd. Identifier:
First received: September 20, 2010
Last updated: June 19, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2013
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)